{
    "paper_id": "36f02ff405db0ad6f66da05029520f59c6987fb1",
    "metadata": {
        "title": "Actualizaci\u00f3n en anemia y terapia transfusional",
        "authors": [
            {
                "first": "Z",
                "middle": [],
                "last": "Madrazo-Gonz\u00e1lez",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Servicio de Cirug\u00eda General y Aparato Digestivo",
                    "institution": "Hospital Universitario de Bellvitge",
                    "location": {
                        "settlement": "Barcelona",
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            },
            {
                "first": "A",
                "middle": [],
                "last": "Garc\u00eda-Barrasa",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Servicio de Cirug\u00eda General y Aparato Digestivo",
                    "institution": "Hospital Universitario de Bellvitge",
                    "location": {
                        "settlement": "Barcelona",
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            },
            {
                "first": "L",
                "middle": [],
                "last": "Rodr\u00edguez-Lorenzo",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Servicio de Angiolog\u00eda y Cirug\u00eda Vascular",
                    "institution": "Hospital Universitario de Bellvitge",
                    "location": {
                        "settlement": "Barcelona"
                    }
                },
                "email": ""
            },
            {
                "first": "A",
                "middle": [],
                "last": "Rafecas-Renau",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Servicio de Cirug\u00eda General y Aparato Digestivo",
                    "institution": "Hospital Universitario de Bellvitge",
                    "location": {
                        "settlement": "Barcelona",
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            },
            {
                "first": "G",
                "middle": [],
                "last": "Alonso-Fern\u00e1ndez",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hospital Universitario de Bellvitge",
                    "location": {
                        "settlement": "Barcelona",
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "effects. It is the responsibility of the clinician to know and to take into account all the available alternatives for the treatment of anemia. Blood transfusions, erythropoiesis-stimulating agents, iron therapy (oral and endovenous) and other therapeutic alternatives must be rationally used, in accordance with the currently available clinical evidence. This review article summarizes some epidemiological characteristics of anemia, its clinical evaluation and the main therapeutic possibilities based on the present knowledge, placing special emphasis on the critically ill patient. \u00a9 2010 Elsevier Espa\u00f1a, S.L. y SEMICYUC. All rights reserved.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "La anemia constituye una de las patolog\u00edas o comorbilidades m\u00e1s prevalentes, especialmente en poblaci\u00f3n de edad avanzada (17-63%) 1, 2 . La anemia, definida por la OMS como unos valores de Hb <13 g/dl en varones adultos y <12 g/dl en mujeres no gestantes, altera la eficacia del aporte tisular de ox\u00edgeno y constituye una de las principales causas de complicaciones y mortalidad, necesidad de ingreso e incremento de la estancia hospitalarios y deterioro de la calidad de vida 1 . La anemia ferrop\u00e9nica, considerada la enfermedad m\u00e1s prevalente del mundo, afecta aproximadamente al 25-30% de la poblaci\u00f3n 3 . La anemia por enfermedad cr\u00f3nica (AEC) constituye la forma m\u00e1s frecuente de anemia en pacientes hospitalizados y cr\u00edticos y representa un tercio de las causas de anemia en pacientes ancianos 1, 3, 4 . La anemia asociada a la insuficiencia renal cr\u00f3nica (secundaria al d\u00e9ficit de eritropoyetina (EPO), AEC, inhibidores de la eritropoyesis, carencias nutricionales y toxicidad ur\u00e9mica, entre otros factores) presenta una elevada prevalencia, proporcional al grado de disfunci\u00f3n renal 2,5-7 . La anemia del paciente oncol\u00f3gico (prevalencia 14-77%) combina caracter\u00edsticas de la AEC y de otros tipos de anemia: ferrop\u00e9nica, megalobl\u00e1stica, mielosupresiva y hemol\u00edtica 8, 9 . Frecuentemente infradiagnosticada e infratratada, representa un factor pron\u00f3stico negativo, incide negativamente en la calidad de vida y puede dificultar la respuesta a la quimioterapia y radioterapia 10, 11 . Los pacientes ingresados en unidades de cr\u00edticos constituyen una poblaci\u00f3n con elevada prevalencia de anemia (40-70%) y requerimientos transfusionales, y responde a una etiolog\u00eda multifactorial [12] [13] [14] [15] [16] . La transfusi\u00f3n de sangre alog\u00e9nica (TSA) representa una medida extraordinariamente \u00fatil para el tratamiento de la anemia y la \u00fanica opci\u00f3n viable para muchos pacientes, pero constituye un recurso limitado (a pesar de los 81 millones de unidades de sangre donadas cada a\u00f1o, seg\u00fan datos de la OMS) y no exento de importantes complicaciones asociadas 9,15-20 .",
            "cite_spans": [
                {
                    "start": 130,
                    "end": 132,
                    "text": "1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 133,
                    "end": 134,
                    "text": "2",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 605,
                    "end": 606,
                    "text": "3",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 800,
                    "end": 802,
                    "text": "1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 803,
                    "end": 805,
                    "text": "3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 806,
                    "end": 807,
                    "text": "4",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1273,
                    "end": 1275,
                    "text": "8,",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1276,
                    "end": 1277,
                    "text": "9",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 1481,
                    "end": 1484,
                    "text": "10,",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 1485,
                    "end": 1487,
                    "text": "11",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1684,
                    "end": 1688,
                    "text": "[12]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 1689,
                    "end": 1693,
                    "text": "[13]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1694,
                    "end": 1698,
                    "text": "[14]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 1699,
                    "end": 1703,
                    "text": "[15]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 1704,
                    "end": 1708,
                    "text": "[16]",
                    "ref_id": "BIBREF15"
                }
            ],
            "ref_spans": [],
            "section": "Introducci\u00f3n Epidemiolog\u00eda general de la anemia"
        },
        {
            "text": "Los objetivos generales del tratamiento de la anemia son minimizar los s\u00edntomas y complicaciones sist\u00e9micas asociados a la hipoxia y mejorar la calidad de vida y supervivencia 21 . En condiciones fisiol\u00f3gicas la distribuci\u00f3n de O 2 (proporcional al gasto cardiaco y contenido sangu\u00edneo de O 2 ) es 4 veces superior al consumo, lo cual garantiza un aporte suficiente para satisfacer las necesida-des tisulares, incluso bajo condiciones de anemia (\u00abreserva fisiol\u00f3gica\u00bb) [22] [23] [24] . La cascada molecular del factor inducible por hipoxia, activada en respuesta a la hipoxia, coordina multitud de genes responsables de cambios adaptativos celulares y tisulares a la hipoxia 25 . Las respuestas adaptativas a la anemia incluir\u00e1n cambios centrales, regionales, microcirculatorios y celulares, con incremento de la extracci\u00f3n tisular de O 2 15,21,22 . Habitualmente se emplea el valor de Hb como indicador tanto de la masa de hemat\u00edes como de la liberaci\u00f3n de O 2 , aunque existen pocos datos en humanos que definan un valor de Hb por debajo del cual, al menos en situaciones de anemia cr\u00f3nica, est\u00e9 comprometida la liberaci\u00f3n de ox\u00edgeno y se manifieste la hipoxia tisular 26, 27 . Bas\u00e1ndonos en par\u00e1metros indirectos (saturaci\u00f3n arterial de O 2 , niveles de lactato) se considera el umbral transfusional (transfusion trigger) en pacientes normovol\u00e9micos sin patolog\u00eda cardiovascular en torno a 7 g/dl de Hb 4, 13, 15, 16, 18, [21] [22] [23] 27 . El trabajo de investigaci\u00f3n de Quintana et al (cuestionario en 84 UCI espa\u00f1olas) confirma el valor fundamentalmente orientativo de las cifras de Hb para el empleo de la TSA (tasa de TSA 20-40%), aunque la indicaci\u00f3n parece un\u00e1nime con valores de Hb <7 g/dl (10 g/dl en caso de cardiopat\u00eda) 28 . H\u00e9bert et al 4 comprobaron en 1999 (estudio TRICC, ensayo cl\u00ednico randomizado (ECR) con 838 pacientes cr\u00edticos con normovolemia) la equivalencia, en t\u00e9rminos de complicaciones y mortalidad, de una estrategia transfusional restrictiva (umbral transfusional 7 g/dl, manteniendo cifras de Hb de 7-9 g/dl) frente a otra m\u00e1s liberal (umbral transfusional 10 g/dl, rango 10-12 g/dl), permitiendo la estrategia restrictiva una reducci\u00f3n del 54% del n\u00famero de transfusiones (2,6 vs 5,6 concentrados de hemat\u00edes/paciente) 13, 15, 18 ; Los autores comprobaron, asimismo, un descenso en la mortalidad a 30 d\u00edas con la estrategia restrictiva en el subgrupo de pacientes con un score APACHE-II \u226420 (8,7% vs 16,1%) y en enfermos <55 a\u00f1os (5,7% vs 13%) 4 . Los pacientes cr\u00edticos con eventos isqu\u00e9micos agudos y en fases iniciales de sepsis grave podr\u00edan representar excepciones notables a la seguridad de una estrategia transfusional restrictiva (umbral recomendado Hb <8-10 g/dl) 16, 29 . Por otra parte, el incremento de Hb y de O 2 disponible no siempre se asocian a un incremento paralelo del consumo tisular de O 2 y una reversi\u00f3n de los efectos delet\u00e9reos de la anemia 20, 23, 26, 27, 30 . La explicaci\u00f3n a tal fen\u00f3meno puede ser multifactorial (depleci\u00f3n de 2,3-bifosfoglicerato, rigidez de los hemat\u00edes almacenados, disfunci\u00f3n mitocondrial) 23 . Investigaciones recientes cuestionan la validez de la Hb como indicador universal de TSA, sugiriendo otros par\u00e1metros de consumo y oxigenaci\u00f3n tisular como posibles indicadores fisiol\u00f3gicos de TSA (saturaci\u00f3n venosa mezclada, presi\u00f3n tisular de O 2 intracerebral, \u00edndice de extracci\u00f3n de ox\u00edgeno (near-infrared spectroscopy), latencia de procesamiento del sistema nervioso central (latencia P300), pH de la mucosa g\u00e1strica, etc.) 13, 21, 22, 26, 30 . A pesar de su empleo universal, no est\u00e1 claramente demostrado que la TSA mejore sistem\u00e1ticamente la oxigenaci\u00f3n tisular o el pron\u00f3stico de los pacientes an\u00e9micos 23, 27, [29] [30] [31] . El estudio de Leal-Noval et al (prospectivo, 60 pacientes neurotraum\u00e1ticos an\u00e9micos y estables) comprob\u00f3 un incremento en la oxigenaci\u00f3n tisular cerebral (presi\u00f3n parcial de ox\u00edgeno cerebral P bt O 2 ) a las 6 h de la TSA (78% de los casos), m\u00e1s frecuente en los enfermos con menores P bt O 2 basales 32 . El trabajo de Zygun et al (ECR, 30 pacientes con TCE grave) confirma un incremento de P bt O 2 (57% de los casos) proporcional al incremento de Hb post-transfusional, m\u00e1s pronunciado en pacientes con \u00edndice lactato/piruvato >25, pero sin efecto sobre el metabolismo cerebral 33 . Hasta la fecha, no disponemos de estudios que apoyen firmemente el empleo de la TSA en el tratamiento de la anemia en pacientes cr\u00edticos hemodin\u00e1micamente estables sin evidencia de sangrado agudo, y los datos disponibles confirman que cifras de Hb de 7-9 g/dl son bien toleradas por la mayor\u00eda de pacientes cr\u00edticos sin hemorragia aguda 13, 27, 29 . Actualmente se recomienda valorar la utilizaci\u00f3n de TSA en funci\u00f3n de par\u00e1metros fisiol\u00f3gicos, sin constituir el valor aislado de Hb un criterio exclusivo o suficiente 23, 31 . Napolitano et al publicaron recientemente una gu\u00eda cl\u00ednica sobre TSA especialmente orientada al paciente cr\u00edtico y traum\u00e1tico 27 . Los autores consideran claramente indicada la TSA en enfermos con evidencia de shock hemorr\u00e1gico y potencialmente indicada ante sangrados agudos asociados a inestabilidad hemodin\u00e1mica o insuficiente disponibilidad de ox\u00edgeno, recomendando una estrategia transfusional restrictiva (Hb <7 g/dl) en pacientes an\u00e9micos estables, con la posible excepci\u00f3n de enfermos con isquemia mioc\u00e1rdica (nivel 1 de recomendaci\u00f3n). Sugieren asociar el valor de Hb al status hemodin\u00e1mico, duraci\u00f3n de la anemia y otros par\u00e1metros cardiopulmonares como indicadores de TSA (nivel 2 de recomendaci\u00f3n); Finalmente, la gu\u00eda recoje una serie de medidas encaminadas a reducir las necesidades de TSA: utilidad potencial de la eritropoyetina recombinante, reducci\u00f3n de extracciones sangu\u00edneas (en n\u00famero y volumen) y empleo de dispositivos de reinfusi\u00f3n de muestras sangu\u00edneas y recuperaci\u00f3n perioperatoria 27 .",
            "cite_spans": [
                {
                    "start": 176,
                    "end": 178,
                    "text": "21",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 469,
                    "end": 473,
                    "text": "[22]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 474,
                    "end": 478,
                    "text": "[23]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 479,
                    "end": 483,
                    "text": "[24]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 675,
                    "end": 677,
                    "text": "25",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 837,
                    "end": 847,
                    "text": "2 15,21,22",
                    "ref_id": null
                },
                {
                    "start": 1171,
                    "end": 1174,
                    "text": "26,",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 1175,
                    "end": 1177,
                    "text": "27",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 1406,
                    "end": 1408,
                    "text": "4,",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1409,
                    "end": 1412,
                    "text": "13,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1413,
                    "end": 1416,
                    "text": "15,",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 1417,
                    "end": 1420,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1421,
                    "end": 1424,
                    "text": "18,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 1425,
                    "end": 1429,
                    "text": "[21]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 1430,
                    "end": 1434,
                    "text": "[22]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 1435,
                    "end": 1439,
                    "text": "[23]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1440,
                    "end": 1442,
                    "text": "27",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 1735,
                    "end": 1737,
                    "text": "28",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 2253,
                    "end": 2256,
                    "text": "13,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 2257,
                    "end": 2260,
                    "text": "15,",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 2261,
                    "end": 2263,
                    "text": "18",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 2478,
                    "end": 2479,
                    "text": "4",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 2707,
                    "end": 2710,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 2711,
                    "end": 2713,
                    "text": "29",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 2901,
                    "end": 2904,
                    "text": "20,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 2905,
                    "end": 2908,
                    "text": "23,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 2909,
                    "end": 2912,
                    "text": "26,",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 2913,
                    "end": 2916,
                    "text": "27,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 2917,
                    "end": 2919,
                    "text": "30",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 3075,
                    "end": 3077,
                    "text": "23",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 3510,
                    "end": 3513,
                    "text": "13,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 3514,
                    "end": 3517,
                    "text": "21,",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 3518,
                    "end": 3521,
                    "text": "22,",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 3522,
                    "end": 3525,
                    "text": "26,",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 3526,
                    "end": 3528,
                    "text": "30",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 3693,
                    "end": 3696,
                    "text": "23,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 3697,
                    "end": 3700,
                    "text": "27,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 3701,
                    "end": 3705,
                    "text": "[29]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 3706,
                    "end": 3710,
                    "text": "[30]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 3711,
                    "end": 3715,
                    "text": "[31]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 4299,
                    "end": 4301,
                    "text": "33",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 4641,
                    "end": 4644,
                    "text": "13,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 4645,
                    "end": 4648,
                    "text": "27,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 4649,
                    "end": 4651,
                    "text": "29",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 4822,
                    "end": 4825,
                    "text": "23,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 4826,
                    "end": 4828,
                    "text": "31",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 4957,
                    "end": 4959,
                    "text": "27",
                    "ref_id": "BIBREF26"
                }
            ],
            "ref_spans": [],
            "section": "Valoraci\u00f3n general de la anemia"
        },
        {
            "text": "La anemia de los pacientes ingresados en unidades de cuidados intensivos representa una entidad extremadamente prevalente (40-70%), constituyendo la alteraci\u00f3n anal\u00edtica m\u00e1s frecuente 16, 20, 34 . En los enfermos cr\u00edticos, la anemia presenta un origen multifactorial: AEC, hemorragia perioperatoria, extracciones frecuentes de anal\u00edticas, hemorragia digestiva, coagulopat\u00eda, t\u00e9cnicas extracorp\u00f3reas, d\u00e9ficits nutricionales y/o f\u00e9rricos, hemodiluci\u00f3n, hem\u00f3lisis, f\u00e1rmacos que interfieren con eritropoyesis (IECA) 4, 12, 16, 24, 35 . La AEC representa probablemente la etiolog\u00eda m\u00e1s frecuente (hasta 50%), definida como una Hb <13 g/dl asociada a un proceso inflamatorio (evidencia cl\u00ednica o biol\u00f3gica, como PCR >1-5 mg/l), con cifras de ferritina >100 ug/l e IST <16-20% 16, 34 . El d\u00e9ficit funcional de hierro (DFH), sustrato de la AEC, es consecuencia de la retenci\u00f3n f\u00e9rrica en los dep\u00f3sitos biol\u00f3gicos (macr\u00f3fagos del sistema ret\u00edculoendotelial) y la inhibici\u00f3n de su absorci\u00f3n intestinal (degradaci\u00f3n y downregulation del transportador intestinal ferroportina-1 y upregulation de DMT-1 e incremento de ferritina), reduciendo su disponibilidad para la eritropoyesis medular 16, 36, 37 . En la AEC coexiste una inhibici\u00f3n de la proliferaci\u00f3n de precursores eritroides y de la s\u00edntesis y respuesta medular a la eritropoyetina end\u00f3gena y stem cell factor 36, 37 . La hormona hepcidina y otras citoquinas proinflamatorias (TNF\u2423, IFN\u2425, IL-1), activamente sintetizadas en procesos inflamatorios, infecciosos, traum\u00e1ticos y neopl\u00e1sicos, se consideran los agentes efectores responsables de la AEC 16, 34, 36, 37 . El DFH es tambi\u00e9n responsable de una alteraci\u00f3n de la respuesta inmune en pacientes cr\u00edticos, contribuyendo a una mayor duraci\u00f3n de la respuesta inflamatoria, estancia y peor pron\u00f3stico 34, 38 . Las posibilidades terap\u00e9uticas en la anemia del paciente cr\u00edtico (analizadas con detalle m\u00e1s adelante) pueden agruparse en: TSA; Tratamiento farmacol\u00f3gico (estimuladores eritropoy\u00e9ticos, ferroterapia, antifibrinol\u00edticos/hemost\u00e1ticos); programas de donaci\u00f3n aut\u00f3loga y/o reinfusi\u00f3n sangu\u00ednea; criterios transfusionales restrictivos e individualizados 24 .",
            "cite_spans": [
                {
                    "start": 184,
                    "end": 187,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 188,
                    "end": 191,
                    "text": "20,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 192,
                    "end": 194,
                    "text": "34",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 512,
                    "end": 514,
                    "text": "4,",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 515,
                    "end": 518,
                    "text": "12,",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 519,
                    "end": 522,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 523,
                    "end": 526,
                    "text": "24,",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 527,
                    "end": 529,
                    "text": "35",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 770,
                    "end": 773,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 774,
                    "end": 776,
                    "text": "34",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 1177,
                    "end": 1180,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1181,
                    "end": 1184,
                    "text": "36,",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 1185,
                    "end": 1187,
                    "text": "37",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 1355,
                    "end": 1358,
                    "text": "36,",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 1359,
                    "end": 1361,
                    "text": "37",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 1592,
                    "end": 1595,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1596,
                    "end": 1599,
                    "text": "34,",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 1600,
                    "end": 1603,
                    "text": "36,",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 1604,
                    "end": 1606,
                    "text": "37",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 1795,
                    "end": 1798,
                    "text": "34,",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 1799,
                    "end": 1801,
                    "text": "38",
                    "ref_id": "BIBREF37"
                }
            ],
            "ref_spans": [],
            "section": "Epidemiolog\u00eda de la anemia en el paciente cr\u00edtico"
        },
        {
            "text": "La TSA representa una medida r\u00e1pida y eficaz para restablecer los valores fisiol\u00f3gicos de Hb e incrementar as\u00ed la capacidad transportadora de O 2 , especialmente \u00fatil en el contexto de anemia grave y/o hemorragia activa, pero no est\u00e1 exenta de importantes complicaciones: transmisi\u00f3n de enfermedades infecciosas (por imposibilidad de detecci\u00f3n viral, \u00abperiodos ventana\u00bb o nuevas infecciones emergentes), riesgo de reacciones de tipo inmune (al\u00e9rgicas, hemol\u00edticas, etc.), reacciones no inmunes (error transfusional, sobrecarga f\u00e9rrica, etc.), complicaciones cardiopulmonares y tromboemb\u00f3licas, infecciones y otras complicaciones postoperatorias, prolongaci\u00f3n de la estancia y mortalidad hospitalarias, recurrencia neopl\u00e1sica, leucoencefalopat\u00eda posterior reversible, etc 12, 13, [17] [18] [19] [20] 30, [39] [40] [41] . Las complicaciones y efectos adversos potenciales asociados a la TSA deben sopesarse con los conocidos incrementos en morbimortalidad secundarios a la anemia 23, 42 . M\u00faltiples trabajos han sugerido un incremento de mortalidad asociado a TSA 42 . Varios estudios observacionales multic\u00e9ntricos evidencian (evidencia 2a) una asociaci\u00f3n entre TSA e incremento de la morbimortalidad (dosis-dependiente) en pacientes cr\u00edticos 13, 20, 23 . El estudio ABC (146 UCI europeas, N=3.534 casos) revel\u00f3 un incremento de la estancia y del porcentaje de disfunci\u00f3n multiorg\u00e1nica y mortalidad en pacientes receptores de TSA (mortalidad 23 vs 17%, p=0,002) 12 . El estudio CRIT (284 UCI en EE.UU., N=4.892 casos) confirm\u00f3 un incremento en la estancia y mortalidad en pacientes cr\u00edticos que recibieron TSA (riesgo ajustado de mortalidad 1,65, p<0,001) 31 . Sin embargo, otros trabajos cuestionan el incremento de mortalidad asociada a TSA en pacientes cr\u00edticos, como el estudio SOAP (198 UCI europeas, N=3147 casos), donde el an\u00e1lisis multivariante no demostr\u00f3 una asociaci\u00f3n entre TSA y peor pron\u00f3stico (RR 0,89, p=0,159) 42 . El reciente metaan\u00e1lisis de Marik et al 15 (45 estudios con 272.596 pacientes) confirma la TSA como factor predictor independiente de mortalidad (OR 1,7), infecci\u00f3n nosocomial y distress respiratorio agudo en enfermos de riesgo. Asimismo, el estudio retrospectivo de Khorana et al 9 (multic\u00e9ntrico, N=504.208 pacientes hospitalizados por enfermedad neopl\u00e1sica) confirm\u00f3 incrementos significativos de los riesgos de tromboembolismo venoso, arterial y mortalidad hospitalaria (OR 1,3) en pacientes receptores de TSA.",
            "cite_spans": [
                {
                    "start": 771,
                    "end": 774,
                    "text": "12,",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 775,
                    "end": 778,
                    "text": "13,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 779,
                    "end": 783,
                    "text": "[17]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 784,
                    "end": 788,
                    "text": "[18]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 789,
                    "end": 793,
                    "text": "[19]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 794,
                    "end": 798,
                    "text": "[20]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 799,
                    "end": 802,
                    "text": "30,",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 803,
                    "end": 807,
                    "text": "[39]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 808,
                    "end": 812,
                    "text": "[40]",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 813,
                    "end": 817,
                    "text": "[41]",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 978,
                    "end": 981,
                    "text": "23,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 982,
                    "end": 984,
                    "text": "42",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 1062,
                    "end": 1064,
                    "text": "42",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 1242,
                    "end": 1245,
                    "text": "13,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1246,
                    "end": 1249,
                    "text": "20,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1250,
                    "end": 1252,
                    "text": "23",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1461,
                    "end": 1463,
                    "text": "12",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 1655,
                    "end": 1657,
                    "text": "31",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 1926,
                    "end": 1928,
                    "text": "42",
                    "ref_id": "BIBREF41"
                }
            ],
            "ref_spans": [],
            "section": "Complicaciones asociadas a la TSA"
        },
        {
            "text": "El riesgo de transmisi\u00f3n sangu\u00ednea de pat\u00f3genos ha disminuido dr\u00e1sticamente en las \u00faltimas d\u00e9cadas con la introducci\u00f3n de t\u00e9cnicas de amplificaci\u00f3n de \u00e1cidos nucleicos y otros m\u00e9todos de screening 18 ",
            "cite_spans": [
                {
                    "start": 197,
                    "end": 199,
                    "text": "18",
                    "ref_id": "BIBREF17"
                }
            ],
            "ref_spans": [],
            "section": "Complicaciones infecciosas asociadas a la TSA"
        },
        {
            "text": "Las complicaciones no infecciosas representan el grupo de efectos adversos m\u00e1s frecuente tras TSA 41 . Entre las reacciones inmunes destacan: reacciones hemol\u00edticas, reacciones febriles, reacciones al\u00e9rgicas, p\u00farpura postransfusional, efecto injerto contra hu\u00e9sped, aloinmunizaci\u00f3n, efectos TRALI y TRIM 41 . Respecto a las complicaciones no inmunes, destacan el error transfusional, sobrecarga f\u00e9rrica, desequilibrios metab\u00f3licos y efecto TACO 41 . El error en la administraci\u00f3n de componentes sangu\u00edneos encabeza el ranking de complicaciones no infecciosas asociadas a TSA 46 . El informe SHOT (Serious Hazards Of Transfusion), en su 12. \u2022 informe anual (2008), registr\u00f3 un 45% de eventos (477 casos) relacionados con errores transfusionales, seguido en orden de frecuencia por la reacci\u00f3n al\u00e9rgica aguda (29%), los eventos relacionados con Ig anti-D (13%) y las reacciones hemol\u00edticas (5%) 41, 46 . La tasa de errores transfusionales se situar\u00eda en torno a 16,8 por 100.000 componentes, con una incidencia de transfusi\u00f3n ABO incompatible en torno a 1:40.000 43, 46 . Las reacciones al\u00e9rgicas postransfusionales poseen una prevalencia extremadamente variable (1-3% en formas urticariformes y 1:20.000-50.000 en las formas anafilactoides), con un amplio rango de s\u00edntomas y signos asociados 19, 41, 43, 47 . El resto de mecanismos no infecciosos por los cuales la TSA incrementa las complicaciones y mortalidad son diversos, pero destacar\u00edamos la producci\u00f3n de lesi\u00f3n pulmonar aguda (TRALI, transfusion-related acute lung injury), el efecto inmunosupresor (TRIM, transfusion-related immunomodulation), la sobrecarga circulatoria (TACO, transfusion-associated circulatory overload) y alteraciones de la microcirculaci\u00f3n, aunque no siempre es posible individualizar la contribuci\u00f3n particular de cada uno de ellos 16, 18, 41, 47 . El efecto TRALI constituye un efecto adverso grave de etiolog\u00eda incierta y representa uno de los principales responsables de la iatrogenia postransfusional 43, 48 . Frecuentemente infradiagnosticado, actualmente se considera la complicaci\u00f3n m\u00e1s frecuente y grave asociada a TSA, representando la principal causa de muerte relacionada con TSA en EE.UU. (seguida de las reacciones hemol\u00edticas y sepsis) 21, 48 . Se caracteriza por lesi\u00f3n pulmonar aguda asociada a edema pulmonar bilateral no cardiog\u00e9nico, hipoxemia, disnea, taquipnea, cianosis, hipotensi\u00f3n y fiebre 16 ; aparece en las primeras horas despu\u00e9s de una TSA, pudiendo considerarse una forma particular de s\u00edndrome de distress respiratorio agudo 43, 48 . Anticuerpos antiHLA y antigranulocitos, l\u00edpidos reactivos y citocinas del donante (especialmente, donantes femeninas) frente a leucocitos del receptor han sido propuestos como agentes etiol\u00f3gicos, estimulando la liberaci\u00f3n de oxidasas, mediadores inflamatorios y complemento, alterando la permeabilidad e integridad de la microcirculaci\u00f3n pulmonar y desencadenando el efecto TRALI 19, 43 . Su incidencia se estima en 1:4.000-1:8.000 transfusiones, con una mortalidad global asociada del 5-25%; precisa tratamiento conservador (ox\u00edgeno, fluidoterapia endovenosa) y, ocasionalmente, ventilaci\u00f3n mec\u00e1nica y otras maniobras invasivas 19, 43 . El efecto TRIM constituye un estado de inmunosupresi\u00f3n vinculado a la TSA que se asocia (estudios observacionales) a un mayor incidencia de neumon\u00eda, infecci\u00f3n urinaria, mediastinitis, sepsis, infecci\u00f3n postoperatoria, reactivaci\u00f3n de virus latentes y, tras cirug\u00eda oncol\u00f3gica, a un aumento de la recurrencia neopl\u00e1sica. Las sustancias vasoactivas liberadas por los leucocitos y linfocitos transfundidos podr\u00edan ser responsables de este efecto inmunomodulador, asociado a una infrarregulaci\u00f3n de la inmunidad celular (disfunci\u00f3n de c\u00e9lulas natural killer, c\u00e9lulas T y c\u00e9lulas presentadoras de ant\u00edgenos, etc.) y una suprarregulaci\u00f3n de la inmunidad humoral (IL4, IL5, IL6, IL10) 16, 18, 19 . Aunque no existen datos concluyentes de una reducci\u00f3n de las tasas de infecci\u00f3n, complicaciones, mortalidad o recurrencia neopl\u00e1sica con la depleci\u00f3n de leucocitos en las TSA (con la salvedad de cirug\u00eda cardiaca, donde se ha documentado una reducci\u00f3n en la mortalidad a corto plazo), la leucodepleci\u00f3n universal (pr\u00e1ctica eliminaci\u00f3n de los leucocitos en los componentes sangu\u00edneos alog\u00e9nicos mediante filtros espec\u00edficos) ha sido implantada en la Uni\u00f3n Europea (desde 2002 en nuestro pa\u00eds) 18, 19, 21, 23, 49 . Un tiempo de almacenamiento prolongado de las bolsas de concentrados de hemat\u00edes (\u00ablesi\u00f3n por almacenamiento\u00bb) podr\u00eda implicar el deterioro morfol\u00f3gico (alteraci\u00f3n de la membrana y p\u00e9rdida de elasticidad y capacidad de deformaci\u00f3n) y funcional (disminuci\u00f3n de 2,3-bifosfoglicerato, \u00f3xido n\u00edtrico y ATP) de los eritrocitos, con cambios delet\u00e9reos en su vida media y afinidad por el ox\u00edgeno y capacidad para favorecer la vasoconstricci\u00f3n, lesi\u00f3n endotelial, isquemia tisular y, presumiblemente, la infecci\u00f3n 15, 18, 23, 43, 50 . Varios estudios observacionales evidencian una asociaci\u00f3n entre TSA almacenada >2-3 semanas y la aparici\u00f3n de complicaciones postoperatorias, estancia hospitalaria y/o mortalidad a corto/largo plazo 50 . M\u00faltiples sustancias presentan concentraciones elevadas en las bolsas de hemat\u00edes almacenadas (histamina, prote\u00edna eosinof\u00edlica cati\u00f3nica, mieloperoxidasa, l\u00edpidos, etc.), y pueden actuar como reguladores inmunes y contribuir al desarrollo de inmunosupresi\u00f3n, efecto TRALI y lesi\u00f3n tisular 51 . La sobrecarga circulatoria secundaria a TSA o TACO es secundaria a una alteraci\u00f3n del gradiente hidrost\u00e1tico alveolocapilar por sobrecarga de volumen, con una incidencia estimada del 1-11% y un amplio espectro de s\u00edntomas, resultando especialmente vulnerables aquellos pacientes con patolog\u00eda cardiopulmonar, insuficiencia renal y ni\u00f1os 16, 41 .",
            "cite_spans": [
                {
                    "start": 98,
                    "end": 100,
                    "text": "41",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 304,
                    "end": 306,
                    "text": "41",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 445,
                    "end": 447,
                    "text": "41",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 575,
                    "end": 577,
                    "text": "46",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 893,
                    "end": 896,
                    "text": "41,",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 897,
                    "end": 899,
                    "text": "46",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 1061,
                    "end": 1064,
                    "text": "43,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 1065,
                    "end": 1067,
                    "text": "46",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 1292,
                    "end": 1295,
                    "text": "19,",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 1296,
                    "end": 1299,
                    "text": "41,",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 1300,
                    "end": 1303,
                    "text": "43,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 1304,
                    "end": 1306,
                    "text": "47",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 1813,
                    "end": 1816,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1817,
                    "end": 1820,
                    "text": "18,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 1821,
                    "end": 1824,
                    "text": "41,",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 1825,
                    "end": 1827,
                    "text": "47",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 1986,
                    "end": 1989,
                    "text": "43,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 1990,
                    "end": 1992,
                    "text": "48",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 2231,
                    "end": 2234,
                    "text": "21,",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 2235,
                    "end": 2237,
                    "text": "48",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 2395,
                    "end": 2397,
                    "text": "16",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 2536,
                    "end": 2539,
                    "text": "43,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 2540,
                    "end": 2542,
                    "text": "48",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 2926,
                    "end": 2929,
                    "text": "19,",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 2930,
                    "end": 2932,
                    "text": "43",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 3175,
                    "end": 3178,
                    "text": "19,",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 3179,
                    "end": 3181,
                    "text": "43",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 3863,
                    "end": 3866,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 3867,
                    "end": 3870,
                    "text": "18,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 3871,
                    "end": 3873,
                    "text": "19",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 4367,
                    "end": 4370,
                    "text": "18,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 4371,
                    "end": 4374,
                    "text": "19,",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 4375,
                    "end": 4378,
                    "text": "21,",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 4379,
                    "end": 4382,
                    "text": "23,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 4383,
                    "end": 4385,
                    "text": "49",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 4894,
                    "end": 4897,
                    "text": "15,",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 4898,
                    "end": 4901,
                    "text": "18,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 4902,
                    "end": 4905,
                    "text": "23,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 4906,
                    "end": 4909,
                    "text": "43,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 4910,
                    "end": 4912,
                    "text": "50",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 5409,
                    "end": 5411,
                    "text": "51",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 5751,
                    "end": 5754,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 5755,
                    "end": 5757,
                    "text": "41",
                    "ref_id": "BIBREF40"
                }
            ],
            "ref_spans": [],
            "section": "Complicaciones no infecciosas asociadas a la TSA"
        },
        {
            "text": "La recuperaci\u00f3n de las cifras de Hb por medios distintos a la TSA contribuir\u00eda a la mejor\u00eda cl\u00ednica del paciente y a la reducci\u00f3n de complicaciones y mortalidad, evitando transfusiones innecesarias en muchos casos 4,16-18,20,28 . La administraci\u00f3n de hierro (oral o parenteral) y agentes estimuladores de la eritropoyesis (ESA) representan las 2 medidas farmacol\u00f3gicas m\u00e1s empleadas como alternativas eficaces a la TSA 5, 16, 52 . Asimismo, los programas de donaci\u00f3n aut\u00f3loga preoperatoria y el empleo de f\u00e1rmacos antifibrinol\u00edticos y hemost\u00e1ticos han conseguido reducir eficazmente la necesidad de TSA en m\u00faltiples disciplinas quir\u00fargicas (en asociaci\u00f3n con ESA y/o ferroterapia adyuvantes) 53 .",
            "cite_spans": [
                {
                    "start": 419,
                    "end": 421,
                    "text": "5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 422,
                    "end": 425,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 426,
                    "end": 428,
                    "text": "52",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 692,
                    "end": 694,
                    "text": "53",
                    "ref_id": "BIBREF52"
                }
            ],
            "ref_spans": [],
            "section": "Alternativas a la TSA"
        },
        {
            "text": "La EPO humana es un polip\u00e9ptido de 165 amino\u00e1cidos sintetizado principalmente en las c\u00e9lulas peritubulares del intersticio renal en respuesta al descenso del hematocrito, hipoxemia y/o incremento en la afinidad de la Hb por el O 2 . La expresi\u00f3n g\u00e9nica de la EPO est\u00e1 regulada por multitud de factores de transcripci\u00f3n, entre los que destaca la v\u00eda del factor inducible por hipoxia, activada en respuesta a la hipoxia 25, 54 . La EPO constituye la principal hormona reguladora de la eritropoyesis medular 3,55 . Distintos tipos de EPO ex\u00f3gena recombinante (rHuEPO), darbepoetina alfa y metoxi polietilenglicol epoetina beta (CERA o activador continuo del receptor de la EPO) constituyen los principales agentes eritropoy\u00e9ticos (ESA) disponibles en el mercado 54 . La administraci\u00f3n de rHuEPO, iniciada a principios de la d\u00e9cada de los 90, ha demostrado firmemente su eficacia en el tratamiento de la anemia en pacientes nefrol\u00f3gicos, oncol\u00f3gicos, hematol\u00f3gicos, hepat\u00f3patas, AEC, anemia asociada al tratamiento del SIDA, anemia del prematuro y en cirug\u00eda mayor electiva ortop\u00e9dica, cardiovascular, digestiva y ginecol\u00f3gica (en programas de donaci\u00f3n aut\u00f3loga o perioperatoria) 2, 5, 7, 17, 53, [56] [57] [58] . Tras su administraci\u00f3n (subcut\u00e1nea o endovenosa), los ESA imitan los efectos de la EPO end\u00f3gena y estimulan la eritropoyesis al inhibir la apoptosis de los precursores eritroides y promover su proliferaci\u00f3n y maduraci\u00f3n 5, 17 . La respuesta cl\u00ednica (73-96%) se manifiesta en un incremento de los reticulocitos en 3-10 d\u00edas y de hemat\u00edes en 1-2 semanas 17 . La intensidad de la respuesta depender\u00e1 de la dosis de ESA, enfermedades inflamatorias y/o sist\u00e9micas concomitantes y de la disponibilidad de otros sustratos indispensables para la eritropoyesis (hierro, vitamina B 12 y \u00e1cido f\u00f3lico) 17 . Sin embargo, su uso resulta caro y no est\u00e1 exento de importantes riesgos (HTA, tromboembolismos, hipercaliemia, cefalea, aplasia de c\u00e9lulas rojas, reacciones cut\u00e1neas, s\u00edntomas gripales, posibilidad de progresi\u00f3n tumoral y reducci\u00f3n de supervivencia en pacientes neopl\u00e1sicos (en programas de ESA con Hb target >12 g/dl), exacerbaci\u00f3n de la retinopat\u00eda diab\u00e9tica, etc.), precisando un ajuste minucioso de la dosis 14 . En Espa\u00f1a disponemos actualmente de 6 tipos de ESA: epoetina alfa, epoetina beta, epoetina delta, epoetina zeta, darbepoetina alfa y CERA, con diferencias en su composici\u00f3n, afinidad por receptores y vida media 5, 7, 54, 57 . Se est\u00e1n investigando formas de presentaci\u00f3n alternativas de EPO, como v\u00eda inhalada e intramuscular 54 . Nuevas y complejas modificaciones de la mol\u00e9cula de EPO, terapia g\u00e9nica y prote\u00ednas de fusi\u00f3n, estabilizadores del factor inducible por hipoxia y sustancias mim\u00e9ticas (como Hematide \u00ae ) representan futuras l\u00edneas de investigaci\u00f3n y tratamiento en estimulaci\u00f3n eritropoy\u00e9tica 5, 7, 54 . A pesar de una disminuci\u00f3n cualitativa y cuantitativa de la eritropoyesis en pacientes cr\u00edticos, la m\u00e9dula \u00f3sea puede responder a la administraci\u00f3n de ESA 16 . Sin embargo, los datos disponibles sobre la utilidad de los ESA en pacientes cr\u00edticos resultan contradictorios 7 . Los primeros ECR sobre el uso de ESA en pacientes cr\u00edticos (Corwin et al [2002] , Silver et al [2006] ) demostraron una disminuci\u00f3n significativa de las necesidades transfusionales en pacientes tratados con ESA, sin diferencias en t\u00e9rminos de morbilidad y mortalidad 16, 59, 60 . Corwin et al 14 comprobaron recientemente en un ensayo cl\u00ednico multic\u00e9ntrico con 1.460 pacientes cr\u00edticos que la administraci\u00f3n de epoetina alfa (40.000 UI/semana, asociada a hierro) no reduc\u00eda las necesidades transfusionales ni la mortalidad, excepto en el subgrupo de pacientes traum\u00e1ticos que recibieron ESA (riesgo ajustado de mortalidad a los 140 d\u00edas de 0,4). El metaan\u00e1lisis de Zarychanski et al 35 sobre el uso de rHuEPO en 3.326 pacientes cr\u00edticos (epoetina alfa, mayoritariamente a dosis de 40.000 UI/semana) evidenci\u00f3 una peque\u00f1a reducci\u00f3n en el n\u00famero de transfusiones respecto al grupo control (ahorro <0,5 unidades/paciente), sin impacto sobre la mortalidad, estancia hospitalaria, tiempo en UCI o necesidad de ventilaci\u00f3n mec\u00e1nica, por lo que los autores no recomiendan el uso rutinario de ESA en pacientes cr\u00edticos. Es posible que una cuidadosa selecci\u00f3n de los pacientes y un uso juicioso de los tratamientos coadyuvantes consiga optimizar el tratamiento con ESA en pacientes cr\u00edticos (a\u00fan sin indicaci\u00f3n t\u00e9cnica) 16 . Las gu\u00edas EORTC (European Organization for Research and Treatment of Cancer) y SEOM (Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica) sobre el uso de ESA en la anemia en pacientes neopl\u00e1sicos confirman su eficacia en el incremento de Hb, reducci\u00f3n de necesidades transfusionales (hasta un 50%) y mejora de la calidad de vida, aunque sin datos consistentes que confirmen una ventaja en t\u00e9rminos de supervivencia, control local del tumor, tiempo de progresi\u00f3n o intervalo libre de enfermedad 52 . Por otra parte, varios estudios y revisiones recientes (ensayos BEST, ENHANCE, Amgen 2000-0161) evidencian un incremento significativo de tromboembolismo venoso, progresi\u00f3n tumoral locorregional y mortalidad cardiovascular en pacientes afectos de distintas neoplasias en tratamiento con ESA con Hb diana \u226512 g/dl, por lo que diversas autoridades sanitarias recomiendan prudencia respecto a su uso y aconsejan monitorizar la Hb para ajustar con precisi\u00f3n la dosis de ESA que permita evitar la TSA 52,57,58 . Las recomendaciones (a\u00f1o 2007) de la American Society of Clinical Oncology (ASCO) y American Society of Hematology (ASH) sobre el uso de ESA en pacientes oncol\u00f3gicos con anemia asociada al tratamiento quimioter\u00e1pico incluyen iniciar el tratamiento con ESA subcut\u00e1neo ante valores de Hb \u226410 g/dl, monitorizar los dep\u00f3sitos de hierro y administrar suplementos f\u00e9rricos, planteando 12 gr/dl como valor diana de hemoglobina 8 8 . De forma similar, varios estudios (CHOIR, CREATE) evidencian un incremento de complicaciones cardiovasculares y mortalidad global en pacientes con insuficiencia renal cr\u00f3nica en tratamiento con ESA con valores diana de Hb >12 g/dl 5, 7 . El Comit\u00e9 de Medicamentos de Uso Humano (CHMP) de la Agencia Europea de Medicamentos (EMEA) recomienda el uso de ESA en el tratamiento de la anemia sintom\u00e1tica del paciente nefrol\u00f3gico (y neopl\u00e1sico) para alcanzar y mantener un nivel m\u00e1ximo de Hb de 12 g/dl 57 .",
            "cite_spans": [
                {
                    "start": 418,
                    "end": 421,
                    "text": "25,",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 422,
                    "end": 424,
                    "text": "54",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 759,
                    "end": 761,
                    "text": "54",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 1176,
                    "end": 1178,
                    "text": "2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 1179,
                    "end": 1181,
                    "text": "5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1182,
                    "end": 1184,
                    "text": "7,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 1185,
                    "end": 1188,
                    "text": "17,",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 1189,
                    "end": 1192,
                    "text": "53,",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 1193,
                    "end": 1197,
                    "text": "[56]",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 1198,
                    "end": 1202,
                    "text": "[57]",
                    "ref_id": null
                },
                {
                    "start": 1203,
                    "end": 1207,
                    "text": "[58]",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 1430,
                    "end": 1432,
                    "text": "5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1433,
                    "end": 1435,
                    "text": "17",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 1801,
                    "end": 1803,
                    "text": "17",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 2219,
                    "end": 2221,
                    "text": "14",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 2435,
                    "end": 2437,
                    "text": "5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 2438,
                    "end": 2440,
                    "text": "7,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 2441,
                    "end": 2444,
                    "text": "54,",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 2445,
                    "end": 2447,
                    "text": "57",
                    "ref_id": null
                },
                {
                    "start": 2550,
                    "end": 2552,
                    "text": "54",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 2830,
                    "end": 2832,
                    "text": "5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 2833,
                    "end": 2835,
                    "text": "7,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 2836,
                    "end": 2838,
                    "text": "54",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 2996,
                    "end": 2998,
                    "text": "16",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 3175,
                    "end": 3195,
                    "text": "(Corwin et al [2002]",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 3211,
                    "end": 3217,
                    "text": "[2006]",
                    "ref_id": null
                },
                {
                    "start": 3383,
                    "end": 3386,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 3387,
                    "end": 3390,
                    "text": "59,",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 3391,
                    "end": 3393,
                    "text": "60",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 4427,
                    "end": 4429,
                    "text": "16",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 5844,
                    "end": 5845,
                    "text": "8",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 5846,
                    "end": 5847,
                    "text": "8",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 6081,
                    "end": 6083,
                    "text": "5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 6084,
                    "end": 6085,
                    "text": "7",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": "Agentes estimuladores de la eritropoyesis (ESA)"
        },
        {
            "text": "La administraci\u00f3n de suplementos orales de hierro constituye el m\u00e9todo menos invasivo de reposici\u00f3n de los dep\u00f3sitos f\u00e9rricos 17 . Las distintas sales ferrosas disponibles en el mercado (tabla 1) presentan m\u00ednimas diferencias respecto a su absorci\u00f3n (tasa 10-15%) y contienen cantidades variables de hierro elemental. La principal desventaja del hierro oral reside en la elevada frecuencia de efectos adversos gastrointestinales (10-40%, en forma de dolor abdominal, pirosis, n\u00e1useas/v\u00f3mitos, estre\u00f1imiento o diarrea), con tasas de incumplimiento terap\u00e9utico >10-20% [61] [62] [63] . La eficacia del tratamiento depende de su tasa de absorci\u00f3n, condicionada por la cantidad, posolog\u00eda, estado de los dep\u00f3sitos biol\u00f3gicos, actividad eritropoy\u00e9tica y factores intraluminales que interfieran en su absorci\u00f3n 3 . La absorci\u00f3n oral de hierro representa un proceso que frecuentemente no puede compensar las p\u00e9rdidas continuas 63 . Debido al efecto de la hormona hepcidina (regulador clave del metabolismo f\u00e9rrico), la absorci\u00f3n intestinal y la movilizaci\u00f3n de los dep\u00f3sitos de hierro desde los macr\u00f3fagos del sistema ret\u00edculoendotelial se encuentran profundamente inhibidas en caso de AEC, justificando la ineficacia de la ferroterapia oral en su tratamiento y la necesidad de recurrir en numerosas ocasiones a v\u00edas alternativas de administraci\u00f3n (hierro parenteral), asociado o no a ESA 3,6,63 . El tratamiento con hierro oral (2-3 mg/kg/d o 50-400 mg/d) incrementa las cifras de Hb a partir de la 1. a -2. a semana de tratamiento, normalizando las cifras de Hb en 1-4 meses. Es necesario prolongar su administraci\u00f3n varios meses (3-6 meses) para rellenar los dep\u00f3sitos biol\u00f3gicos. El hierro endovenoso, por el contrario, permite una respuesta medular y una repleci\u00f3n m\u00e1s r\u00e1pida de los dep\u00f3sitos (1-2 semanas) 63 .",
            "cite_spans": [
                {
                    "start": 126,
                    "end": 128,
                    "text": "17",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 567,
                    "end": 571,
                    "text": "[61]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 572,
                    "end": 576,
                    "text": "[62]",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 577,
                    "end": 581,
                    "text": "[63]",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 920,
                    "end": 922,
                    "text": "63",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 1805,
                    "end": 1807,
                    "text": "63",
                    "ref_id": "BIBREF61"
                }
            ],
            "ref_spans": [],
            "section": "Ferroterapia oral"
        },
        {
            "text": "Desde 1998 el hierro parenteral se ha convertido en un pilar b\u00e1sico del tratamiento de los pacientes con insuficiencia renal cr\u00f3nica en programas de sustituci\u00f3n renal 6 . Comparada con la ferroterapia oral, la asociaci\u00f3n de ESA y hierro endovenoso resulta superior en t\u00e9rminos de correcci\u00f3n de la anemia de origen renal, neopl\u00e1sica, AEC y perioperatoria, y permite retrasar y reducir las dosis de ESA (hasta un 30-70%) 6, 7, 17 . Esta interdependencia sin\u00e9rgica se basa en el requerimiento de unos dep\u00f3sitos f\u00e9rricos adecuados a fin de mantener la saturaci\u00f3n de transferrina necesaria para una eritropoyesis hiperestimulada por los ESA. Su \u00f3ptimo perfil de seguridad (prevalencia de efectos adversos graves de 2,2-5 casos/mill\u00f3n de dosis) y su contrastada eficacia confieren a las actuales formulaciones de hierro parenteral un enorme potencial como arma terap\u00e9utica en medicina transfusional, constituyendo una alternativa a la TSA sumamente \u00fatil 17, 62 . Globalmente, el hierro endovenoso es m\u00e1s efectivo, predecible, mejor tolerado y mejora m\u00e1s r\u00e1pidamente la calidad de vida en comparaci\u00f3n con los suplementos ferrosos orales 7 . El DFH, caracter\u00edstico de la AEC, responde satisfactoriamente a la administraci\u00f3n de hierro parenteral 63 . Existen distintas formulaciones de hierro parenteral disponibles en el mercado (tabla 2), con diferencias en sus caracter\u00edsticas f\u00edsico-qu\u00edmicas y reg\u00edmenes de dosificaci\u00f3n. Algunas presentaciones posibilitan la administraci\u00f3n de hierro endovenoso a altas dosis (200-1.000 mg/dosis) o en monodosis (total dose infusion), simplificando su posolog\u00eda (reducci\u00f3n del n\u00famero de dosis y estancia) y acelerando as\u00ed la restauraci\u00f3n de los dep\u00f3sitos f\u00e9rricos y la eritropoyesis 62, 63 . Actualmente se consideran indicaciones de hierro endovenoso: intolerancia, incumplimiento, ineficacia o imposibilidad de ferroterapia oral, enfermedades malabsortivas o inflamatorias intestinales, DFH y la necesidad de reposici\u00f3n f\u00e9rrica inmediata para una eritropoyesis eficaz (anemia perioperatoria, tratamiento concomitante con ESA, programas de donaci\u00f3n aut\u00f3loga, anemia asociada a neoplasias y quimioterapia, pacientes en programas de tratamiento renal sustitutorio y anemia asociada al embarazo o puerperio) 6, 56, 62, 63 . Los pacientes cr\u00edticos presentan un DFH dif\u00edcilmente corregible con ferroterapia oral. La eritropoyesis inadecuada y la alteraci\u00f3n inmunitaria asociadas al DFH pueden beneficiarse de la administraci\u00f3n de hierro parenteral, contribuyendo as\u00ed a un descenso de las necesidades transfusionales y a una potencial reducci\u00f3n de la estancia, par\u00e1metros inflamatorios y morbilidad mortalidad (aunque su relaci\u00f3n riesgo/beneficio no est\u00e1 claramente definida) 16 . El estudio de Van Iperen et al evidenci\u00f3 una tendencia a la reducci\u00f3n de las necesidades transfusionales, respuesta inflamatoria y mortalidad en pacientes cr\u00edticos con anemia que recibieron hierro sacarosa endovenoso (solo o asociado a ESA) 64 . Georgopoulos 16 .",
            "cite_spans": [
                {
                    "start": 419,
                    "end": 421,
                    "text": "6,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 422,
                    "end": 424,
                    "text": "7,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 425,
                    "end": 427,
                    "text": "17",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 948,
                    "end": 951,
                    "text": "17,",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 952,
                    "end": 954,
                    "text": "62",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 1237,
                    "end": 1239,
                    "text": "63",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 1711,
                    "end": 1714,
                    "text": "62,",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 1715,
                    "end": 1717,
                    "text": "63",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 2234,
                    "end": 2236,
                    "text": "6,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 2237,
                    "end": 2240,
                    "text": "56,",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 2241,
                    "end": 2244,
                    "text": "62,",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 2245,
                    "end": 2247,
                    "text": "63",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 2699,
                    "end": 2701,
                    "text": "16",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 2945,
                    "end": 2947,
                    "text": "64",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 2963,
                    "end": 2965,
                    "text": "16",
                    "ref_id": "BIBREF15"
                }
            ],
            "ref_spans": [],
            "section": "Hierro parenteral"
        },
        {
            "text": "Los avances en el conocimiento de la fisiopatolog\u00eda de la AEC han posibilitado el desarrollo de nuevas modalidades terap\u00e9uticas 17 . El uso de antagonistas de la hepcidina o de mediadores inflamatorios, as\u00ed como hormonas y citocinas que estimulen la eritropoyesis, constituyen posibles e interesantes estrategias futuras en el tratamiento de la anemia 3, 54 . En el contexto de las especialidades quir\u00fargicas, aparte de los programas de donaci\u00f3n aut\u00f3loga y sistemas cell-savers, disponemos de sustancias antifibrinol\u00edticas y hemost\u00e1ticas para el manejo de la hemorragia perioperatoria y reducci\u00f3n de las necesidades transfusionales, como aprotinina, desmopresina, \u00e1cido -aminocaproico y \u00e1cido tranex\u00e1mico, con eficacia demostrada en cirug\u00eda cardiaca, digestiva y ortop\u00e9dica, entre otras 17, 18, 24 . La aprotinina ejerce un efecto antifibrinol\u00edtico basado en la inhibici\u00f3n de enzimas clave de la fibrinolisis y de la cascada inflamatoria 17, 66 . A pesar de haber demostrado su eficacia en cirug\u00eda cardiaca y otras especialidades quir\u00fargicas, su comercializaci\u00f3n ha sido suspendida a ra\u00edz de un ECR multic\u00e9ntrico que evidenci\u00f3 un incremento de la mortalidad en pacientes sometidos a cirug\u00eda cardiaca que recibieron aprotinina 67 . La desmopresina, an\u00e1logo de la hormona antidiur\u00e9tica, ejerce su efecto hemost\u00e1tico incrementando tanto las concentraciones plasm\u00e1ticas de factor VIII y de Von Willebrand como la adhesi\u00f3n plaquetaria 17 . Su posible beneficio en el paciente cr\u00edtico no est\u00e1 a\u00fan esclarecido 24 . \u00c1cido \u03b5-aminocaproico y \u00e1cido tranex\u00e1mico poseen acci\u00f3n antifibrinol\u00edtica al inhibir tanto la plasmina como la activaci\u00f3n del plasmin\u00f3geno (el \u00e1cido tranex\u00e1mico posee una acci\u00f3n m\u00e1s prolongada y 6-10 veces m\u00e1s potente), con eficacia demostrada en la reducci\u00f3n de p\u00e9rdidas hemorr\u00e1gicas y necesidades transfusionales en disciplinas quir\u00fargicas 17, 68 . El estudio CRASH-2 (ECR multic\u00e9ntrico), actualmente en curso, evaluar\u00e1 el efecto del \u00e1cido tranex\u00e1mico en pacientes traum\u00e1ticos con (o riesgo de) hemorragia significativa en t\u00e9rminos de mortalidad y necesidades transfusionales 24 .",
            "cite_spans": [
                {
                    "start": 128,
                    "end": 130,
                    "text": "17",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 352,
                    "end": 354,
                    "text": "3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 355,
                    "end": 357,
                    "text": "54",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 787,
                    "end": 790,
                    "text": "17,",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 791,
                    "end": 794,
                    "text": "18,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 795,
                    "end": 797,
                    "text": "24",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 938,
                    "end": 941,
                    "text": "17,",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 942,
                    "end": 944,
                    "text": "66",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 1226,
                    "end": 1228,
                    "text": "67",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 1430,
                    "end": 1432,
                    "text": "17",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 1503,
                    "end": 1505,
                    "text": "24",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 1850,
                    "end": 1853,
                    "text": "17,",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 1854,
                    "end": 1856,
                    "text": "68",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 2086,
                    "end": 2088,
                    "text": "24",
                    "ref_id": "BIBREF23"
                }
            ],
            "ref_spans": [],
            "section": "Otras alternativas"
        },
        {
            "text": "Finalmente, las soluciones artificiales transportadoras de ox\u00edgeno (emulsiones de fluorocarbonados y soluciones de Hb artificial) representan prometedoras l\u00edneas de investigaci\u00f3n en terapia de sustituci\u00f3n sangu\u00ednea, aunque los entusiastas resultados iniciales han sido frenados por recientes estudios que suscitan dudas sobre su seguridad, efectos adversos y eficacia cl\u00ednica 17, 18, 47, 69 .",
            "cite_spans": [
                {
                    "start": 376,
                    "end": 379,
                    "text": "17,",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 380,
                    "end": 383,
                    "text": "18,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 384,
                    "end": 387,
                    "text": "47,",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 388,
                    "end": 390,
                    "text": "69",
                    "ref_id": "BIBREF67"
                }
            ],
            "ref_spans": [],
            "section": "Otras alternativas"
        },
        {
            "text": "La anemia representa una entidad extremadamente frecuente en pacientes de todas las disciplinas (especialmente, pacientes cr\u00edticos), precisando un abordaje multidisciplinar y un uso racional e individualizado de los recursos terap\u00e9uticos disponibles. La transfusi\u00f3n de sangre alog\u00e9nica representa una medida r\u00e1pida y eficaz en su correcci\u00f3n, aunque no exenta de importantes complicaciones y controversias. La TSA debe indicarse de forma individualizada en funci\u00f3n de par\u00e1metros fisiol\u00f3gicos, no solo ante cifras bajas de Hb. La aplicaci\u00f3n de alternativas farmacol\u00f3gicas (ESA, ferroterapia y antifibrinol\u00edticos/hemost\u00e1ticos), reducci\u00f3n (en n\u00famero y volumen) de las determinaciones anal\u00edticas, programas de donaci\u00f3n aut\u00f3loga y reinfusi\u00f3n sangu\u00ednea y el empleo de estrategias transfusionales restrictivas puede conseguir una reducci\u00f3n significativa de la demanda de transfusiones sangu\u00edneas y contribuir a un uso m\u00e1s racional, seguro y eficiente de la TSA.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusiones"
        },
        {
            "text": "Los autores declaran no tener ning\u00fan conflicto de intereses.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conflicto de intereses"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Prevalence of anaemia in older persons: systematic review",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Gaskell",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Derry",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Mcquay",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "BMC Geriatrics",
            "volume": "8",
            "issn": "",
            "pages": "1--8",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "The prevalence of anemia in patients with chronic kidney disease",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Mcclellan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Aronoff",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "K"
                    ],
                    "last": "Bolton",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hood",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Lorber",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Tang",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Curr Med Res Opin",
            "volume": "20",
            "issn": "",
            "pages": "1501--1511",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Forging a field: the golden age of iron biology",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "C"
                    ],
                    "last": "Andrews",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Blood",
            "volume": "112",
            "issn": "",
            "pages": "219--249",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "C"
                    ],
                    "last": "H\u00e9bert",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wells",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Blajchman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Marshall",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pagliarello",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "N Engl J Med",
            "volume": "340",
            "issn": "",
            "pages": "409--426",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Anemia in chronic kidney disease: status of new therapies",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fishbane",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Curr Opin Nephrol Hypertens",
            "volume": "18",
            "issn": "",
            "pages": "112--117",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "A comprehensive vision for intravenous iron therapy",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Coyne",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Am J Kidney Dis",
            "volume": "52",
            "issn": "",
            "pages": "14--20",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Triumph and tragedy: anemia management in chronic kidney disease",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Novak",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Szczech",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Curr Opin Nephrol Hypertens",
            "volume": "17",
            "issn": "",
            "pages": "580--588",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Use of epoetin and darbepoetin in patients with cancer",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Rizzo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Somerfield",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Hagerty",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Seidenfeld",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bohlius",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Bennett",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Clin Oncol",
            "volume": "26",
            "issn": "",
            "pages": "132--181",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Khorana",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Francis",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Blumberg",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Culakova",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Refaai",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "H"
                    ],
                    "last": "Lyman",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Arch Intern Med",
            "volume": "168",
            "issn": "",
            "pages": "2377--81",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Impact of tumor hypoxia and anemia on radiation therapy outcomes",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "B"
                    ],
                    "last": "Harrison",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chadha",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Hill",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Shasha",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Oncologist",
            "volume": "7",
            "issn": "",
            "pages": "492--508",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Cancer-related anemia: biological findings, clinical implications and impact on quality of life",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "U"
                    ],
                    "last": "Blohmer",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Dunst",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Harrison",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Johnston",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Khayat",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ludwig",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Oncology",
            "volume": "68",
            "issn": "",
            "pages": "12--21",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Anemia and blood transfusion in critically ill patients",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Vincent",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Baron",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Reinhart",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gattinoni",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Thijs",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Webb",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "JAMA",
            "volume": "288",
            "issn": "",
            "pages": "1499--507",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Red blood cell transfusion in the critically ill: when is it time to say enough?",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Corwin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "F"
                    ],
                    "last": "Shorr",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Crit care Med",
            "volume": "37",
            "issn": "",
            "pages": "2114--2120",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Efficacy and safety of epoetin alfa in critically ill patients",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Corwin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gettinger",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "C"
                    ],
                    "last": "Fabian",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "May",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Pearl",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Heard",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "N Engl J Med",
            "volume": "357",
            "issn": "",
            "pages": "965--76",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Marik",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Corwin",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Crit Care Med",
            "volume": "36",
            "issn": "",
            "pages": "1--8",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Prevalencia y tratamiento de la anemia en el paciente cr\u00edtico",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mu\u00f1oz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Leal-Noval",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Garc\u00eda-Erce",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Naveira",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Med Intensiva",
            "volume": "31",
            "issn": "",
            "pages": "388--98",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Sevilla'' de consenso sobre alternativas a la transfusi\u00f3n de sangre alog\u00e9nica",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Alberca",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Asuero",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "B\u00f3veda",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Carpio",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Contreras",
                    "suffix": ""
                },
                {
                    "first": "Fern\u00e1ndez",
                    "middle": [],
                    "last": "Mond\u00e9jar",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Med Clin (Barc)",
            "volume": "127",
            "issn": "",
            "pages": "3--20",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Transfusion-associated complications",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "W"
                    ],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chandhok",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Int Anesthesiol Clin",
            "volume": "42",
            "issn": "",
            "pages": "11--26",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Risks of blood transfusion",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "T"
                    ],
                    "last": "Goodnough",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Crit Care Med",
            "volume": "31",
            "issn": "",
            "pages": "678--86",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Transfusi\u00f3n en el paciente cr\u00edtico",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Leal-Noval",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mu\u00f1oz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Campanario",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Med Intensiva",
            "volume": "28",
            "issn": "",
            "pages": "464--473",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Recommendations for the transfusion of red blood cells",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Liumbruno",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bennardello",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lattanzio",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Piccoli",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Rossetti",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Blood Transfus",
            "volume": "7",
            "issn": "",
            "pages": "49--64",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Anemia and perioperative red blood cell transfusion: a matter of tolerance",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Madjdpour",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "Spahn",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Weiskopf",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Crit Care Med",
            "volume": "34",
            "issn": "",
            "pages": "102--110",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Clinical evidence of blood transfusion effectiveness",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pape",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Stein",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Horn",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Habler",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Blood Transfus",
            "volume": "7",
            "issn": "",
            "pages": "250--258",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "T"
                    ],
                    "last": "Tinmouth",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Mcintyre",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Fowler",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "CMAJ",
            "volume": "178",
            "issn": "",
            "pages": "49--57",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "HIF-1 and HIF-2: working alone or together in hypoxia?",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Ratcliffe",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Clin Invest",
            "volume": "117",
            "issn": "",
            "pages": "862--867",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Effect of transfusion on oxygen transport in critically ill patients",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gramm",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Gamelli",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Dries",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Shock",
            "volume": "5",
            "issn": "",
            "pages": "190--193",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Clinical practice guideline: red blood cell transfusion in adult trauma and critical care",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Napolitano",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kurek",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Luchette",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Anderson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Bard",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Bromberg",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Trauma",
            "volume": "67",
            "issn": "",
            "pages": "1439--1481",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Resultados de una encuesta nacional sobre h\u00e1bito transfusional en unidades de cuidades intensivos",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Quintana",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "S\u00e1nchez",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Leal-Noval",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Garc\u00eda",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Med Intensiva",
            "volume": "33",
            "issn": "",
            "pages": "8--15",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Controversies in RBC transfusion in the critically ill",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "C"
                    ],
                    "last": "H\u00e9bert",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tinmouth",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Corwin",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Chest",
            "volume": "131",
            "issn": "",
            "pages": "1583--90",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Garc\u00eda-Erce",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gomoll\u00f3n",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mu\u00f1oz",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "World J Gastroenterol",
            "volume": "15",
            "issn": "",
            "pages": "4686--94",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "The CRIT study: anemia and blood transfusion in the critically ill-Current clinical practice in the United States",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Corwin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gettinger",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Pearl",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Fink",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Levy",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Abraham",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Crit Care Med",
            "volume": "32",
            "issn": "",
            "pages": "39--52",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Transfusion of erythrocyte concentrates produces a variable increment on cerebral oxygenation in patients with severe traumatic brain injury: a preliminary study",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Leal-Noval",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "D"
                    ],
                    "last": "Rinc\u00f3n-Ferrari",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Marin-Niebla",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cayuela",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Arellano-Orden",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mar\u00edn-Caballos",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Intensive Care Med",
            "volume": "32",
            "issn": "",
            "pages": "1733--1773",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Zygun",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nortje",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Hutchinson",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Timofeev",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "K"
                    ],
                    "last": "Menon",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Gupta",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Crit Care Med",
            "volume": "37",
            "issn": "",
            "pages": "1074--1082",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Iron metabolism, inflammation and anemia in critically ill patients. A cross-sectional study",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mu\u00f1oz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Romero",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Morales",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Campos",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Garc\u00eda-Erce",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ram\u00edrez",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nutr Hosp",
            "volume": "XX",
            "issn": "",
            "pages": "115--135",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Zarychanski",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "F"
                    ],
                    "last": "Turgeon",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mcintyre",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Fergusson",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "CMAJ",
            "volume": "177",
            "issn": "",
            "pages": "725--759",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Serum transferring receptor",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "S"
                    ],
                    "last": "Skikne",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Am J Hematol",
            "volume": "83",
            "issn": "",
            "pages": "872--877",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Anemia of chronic disease",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Weiss",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "T"
                    ],
                    "last": "Goodnough",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "N Engl J Med",
            "volume": "352",
            "issn": "",
            "pages": "1011--1034",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Unrecognised iron deficiency in critical illness",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Bellamy",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Gednaey",
                    "suffix": ""
                }
            ],
            "year": 1903,
            "venue": "Lancet",
            "volume": "352",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Bernard",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Davenport",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "K"
                    ],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "B"
                    ],
                    "last": "Vaughan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Zwischenberger",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Am Coll Surg",
            "volume": "208",
            "issn": "",
            "pages": "931--938",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Transfusion, not just injury severity, leads to posttrauma infection: a matched cohort study",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sadjadi",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "L"
                    ],
                    "last": "Cureton",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Twomey",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "P"
                    ],
                    "last": "Victorino",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Am Surg",
            "volume": "75",
            "issn": "",
            "pages": "307--319",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Noninfectious serious hazards of transfusion",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Hendrickson",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Hillyer",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Anesth Analg",
            "volume": "108",
            "issn": "",
            "pages": "759--69",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Are blood transfusions associated with greater mortality rates? Anesthesiology",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Vincent",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Sakr",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Sprung",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Harboe",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Damas",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "",
            "volume": "108",
            "issn": "",
            "pages": "31--40",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "C"
                    ],
                    "last": "Vamvakas",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Blajchman",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Blood",
            "volume": "113",
            "issn": "",
            "pages": "3406--3423",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "K"
                    ],
                    "last": "Hourfar",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Jork",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Schottstedt",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Weber-Schehl",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Brixner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Busch",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Transfusion",
            "volume": "48",
            "issn": "",
            "pages": "1558--66",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "The continuing risk of transfusion-transmitted infections",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Blajchman",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "C"
                    ],
                    "last": "Vamvakas",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "N Engl J Med",
            "volume": "355",
            "issn": "",
            "pages": "1303--1308",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "On behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Mold",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Asher",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Cawley",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Annual SHOT Report",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Blood transfusion: friend or foe",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Katz",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "AACN Adv Crit Care",
            "volume": "20",
            "issn": "",
            "pages": "155--63",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Acute lung injury following blood transfusion: expanding the definition",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Marik",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Corwin",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Crit Care Med",
            "volume": "36",
            "issn": "",
            "pages": "3080--3084",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Lange",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Van Hilten",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Van De Watering",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "A"
                    ],
                    "last": "Bijnen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Roumen",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Putter",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Br J Surg",
            "volume": "96",
            "issn": "",
            "pages": "734--774",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Duration of red-cell storage and complications after cardiac surgery",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "G"
                    ],
                    "last": "Koch",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "I"
                    ],
                    "last": "Sessler",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Figueroa",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Hoeltge",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Mihaljevic",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "N Engl J Med",
            "volume": "358",
            "issn": "",
            "pages": "1229--1268",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Time-dependent, spontaneous release of white cell-and platelet-derived bioactive substances from stored human blood",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Nielsen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Reimert",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "N"
                    ],
                    "last": "Pedersen",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Br\u00fcnner",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Edvardsen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Dybkjaer",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Transfusion",
            "volume": "36",
            "issn": "",
            "pages": "960--965",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bokemeyer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Aapro",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Courdi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Foubert",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Link",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Osterborg",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Eur J Cancer",
            "volume": "43",
            "issn": "",
            "pages": "258--70",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Autologous blood predonation and perioperative use of erythropoietin",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Michaeli",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ravussin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "G"
                    ],
                    "last": "Chassot",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Rev Med Suisse",
            "volume": "2",
            "issn": "",
            "pages": "2662--2666",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "New erythropoiesis-stimulating agents: how innovative are they?",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Del Vecchio",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Locatelli",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Contrib Nephrol",
            "volume": "161",
            "issn": "",
            "pages": "255--60",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Erythropoietin receptors: their role beyond erythropoiesis",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Rossert",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "U"
                    ],
                    "last": "Eckardt",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nephrology Dialysis Transplantation",
            "volume": "20",
            "issn": "",
            "pages": "1025--1033",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gasch\u00e9",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Dejaco",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Waldhoer",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Tillinger",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Reinisch",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "F"
                    ],
                    "last": "Fueger",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Epoetinas: nuevas recomendaciones de uso",
            "volume": "126",
            "issn": "",
            "pages": "95--101",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Recombinant human erythropoiesisstimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bohlius",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Schmidlin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Brillant",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Schwarzer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Trelle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Seidenfeld",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Lancet",
            "volume": "373",
            "issn": "",
            "pages": "1532--1574",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Efficacy of recombinant human erythropoietin in critically ill patients: a randomized, controlled trial",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Corwin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gettinger",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Pearl",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Fink",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Levy",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Shapiro",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "JAMA",
            "volume": "288",
            "issn": "",
            "pages": "2827--2862",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Silver",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Corwin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bazan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gettinger",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Enny",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Corwin",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Crit Care Med",
            "volume": "34",
            "issn": "",
            "pages": "2310--2316",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Treatment of anemia in inflammatory bowel disease with iron sucrose",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Bodemar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kechagias",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Almer",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "G"
                    ],
                    "last": "Danielson",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Scand J Gastroenterol",
            "volume": "39",
            "issn": "",
            "pages": "454--462",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: The Ferric Carboxymaltose (FERINJECT \u00ae ) Randomized Controlled Trial",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kulnigg",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Stoinov",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Simanenkov",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "V"
                    ],
                    "last": "Dudar",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Karnafel",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "C"
                    ],
                    "last": "Garcia",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Am J Gastroenterol",
            "volume": "103",
            "issn": "",
            "pages": "1182--92",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rozen-Zvi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gafter-Gvili",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Paul",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Leibovici",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Shpilberg",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Gafter",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Am J Kidney Dis",
            "volume": "52",
            "issn": "",
            "pages": "897--906",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "E"
                    ],
                    "last": "Van Iperen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Gaillard",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Kraaijenhagen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "G"
                    ],
                    "last": "Braam",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Marx",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Van De Wiel",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Crit Care Med",
            "volume": "28",
            "issn": "",
            "pages": "2773--2781",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Recombinant human erythropoietin therapy in critically ill patients: a dose-response study",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Georgopoulos",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Matamos",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Routsi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Michalopoulos",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Margina",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Dimopoulos",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Crit Care",
            "volume": "9",
            "issn": "",
            "pages": "508--523",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Perioperative systemic haemostatic agents",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Mahdy",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "R"
                    ],
                    "last": "Webster",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Br J Anaesth",
            "volume": "93",
            "issn": "",
            "pages": "842--58",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "A comparison of aprotinin and lysine analogues in high-risk cardiac surgery",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Fergusson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "C"
                    ],
                    "last": "H\u00e9bert",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Mazer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fremes",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Macadams",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Murkin",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "N Engl J Med",
            "volume": "358",
            "issn": "",
            "pages": "2319--2350",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Oertli",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Laffer",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Haberthuer",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Kreuter",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Harder",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Br J Surg",
            "volume": "81",
            "issn": "",
            "pages": "856--865",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Cell-free haemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Natanson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Kern",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lurie",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Banks",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Wolfe",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "JAMA",
            "volume": "299",
            "issn": "",
            "pages": "2304--2316",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": ",19,41,43,44 . Los microorganismos potencialmente transmisibles a trav\u00e9s de TSA incluyen: virus como VHB (riesgo estimado 1:350.000), VHC (riesgo 1:1.800.000-10.880.000), VIH (riesgo 1:2.300.000-4.300.000), VHA, parvovirus B19, VLTH 1-2, CMV, VEB, West Nile Virus, simian foamy virus, virus del dengue, enterovirus, coronavirus y priones 19,41,43,45 ; bacterias como treponema pallidum y otros g\u00e9neros (staphylococcus, pseudomonas, yersinia, borrelia, serratia y enterobacter); protozoos (g\u00e9neros leishmania, trypanosoma, plasmodium, toxoplasma, babesia). La incidencia de sepsis cl\u00ednica secundaria a TSA se estima en 1:250.000 transfusiones, constituyendo el 14% de todas las muertes atribuidas a TSA en EE.UU. 41 . Asimismo, persiste el riesgo potencial de transmisi\u00f3n sangu\u00ednea de virus a\u00fan desconocidos, virus en expansi\u00f3n geogr\u00e1fica (chikungunya virus, St.Louis encephalitis virus, etc.) y nuevas variantes de la enfermedad de Creutzfeldt-Jakob 18,19,22,44 .",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Tabla 1 Preparados de hierro oral disponibles en Espa\u00f1a",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "et al comprobaron un descenso en el porcentaje de transfusiones (y en el n\u00famero de concentrados empleados) en un grupo de enfermos cr\u00edticos mediante la administraci\u00f3n de hierro endovenoso asociado a ESA (efecto dosis de ESAdependiente), aunque sin efecto en la estancia en UCI ni en la mortalidad65 . El trabajo de revisi\u00f3n de Mu\u00f1oz et al propone una dosis de 50 mg/d (100 mg/d en caso de pacientes sangrantes y/o estimulados por ESA) para cubrir las necesidades eritropoy\u00e9ticas en pacientes cr\u00edticos",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}